International Medical Devices Share Discussion Threads

[keyboard] 02/1/2003 14:21

Also INT being acquisitive, the share price is news-driven.
I too was away for an extended period when the price dipped to
205 (13th August I think)! I first bought INT at 82p so have
been following it for a very long time!

[njp] 02/1/2003 14:04

I saw that 205p low this summer the day after I returned from holiday and thought 'my, that's an opportunity.' Didn't do anything that day, though, as everything was down and INT was too close to the psychological 200p for comfort, plus I was out of tune with the market. Next day it stated the climb back up and fairly rocketed back up to 260p. When INT recovers, it doesn't hang about.

[keyboard] 02/1/2003 13:52

NJP:

INT price has perked up between 10th and 20th February
in the last two years and then made good headway.

2001: High=296.5 (Low=213)
2002: High=297.5 (Low=205)

Good trading today and we might not see the desired 210, I think,
though in these fickle markets, anything is possible in the short-term,
but long-term imo INT remains a solid stock and this year
it could well go beyond 300, given the state of the health-care and
pharmaceutical sectors.

[njp] 02/1/2003 13:16

superrod

Agree with you - an ace share to trade as the business is so sound you know it'll bounce back.

keyboard

In since 31st as I reckoned it would bounce but would certainly double up if it fell to 210p.

[keyboard] 02/1/2003 11:39

Quality stock. Have been in and out of INT a number of times,
and the company has come a long way since it gave up scooters for
the elderly, and started concentrating on generics.

Like NJP, I am now looking to see if it goes down towards 210
and imo 210-220p would be a good buying opportunity.
Sound management and the forward PE ratio
of 11.3 is better than that of many of its peers.
I also follow the buying and selling prices of John Parker, the ceo.
usually a good indicator for me re price movements but dyor.

[boadicea] 01/1/2003 18:37

Last year the final results were announced 3rd week in March.
This gives a probable dull period through to early March this year so no panic rush to get in.
Not quite testing its 220p low yet (226p now) but a couple of bad days in the market generally could generate the right moment for a buy imho.
Looking medium/long term of course. DYOR.

Boad.

[njp] 31/12/2002 10:53

It's about time INT started it's move upwards again. Safe sector, steady profits and sound management. Up to 260p and perhaps beyond this time.

[boadicea] 30/11/2002 17:55

I'm really surprised there isn't more interest in this one. Trading seems stuck between support around 220 and resistance at 260, so one can surmise that we're on the way to 260 at the moment. It will need some sort of kick to get it out of this territory. Upwards or downwards, that is the question!
Historic p/e of 40 looks high but concensus prospective this year is for earnings of 21p (p/e = 12) and next year 24p (p/e falls to 10) which doesn't demand an awful lot for a solid company with real earnings. There is enough information around to make wild/irresponsible speculation/ramping futile. Is this why there is so little BB action?
But at least it should mean that holders can sleep at night and go on holiday without tranquilisers. I'm happy to keep it for the long-term as I think its strategy correctly anticipates the future direction of pharmaceutical supply and distribution. It just needs to keep ahead of the competition.
Waiting to buy more next time it tests the 220 support.
Boad.

[boadicea] 01/11/2002 21:02

Hello - hello - Is anybody there? (other than Andy - Hi!)

This one's looking quite strong the last two weeks, albeit on apparently low volume. Interesting.
I have thought for some time that it has promise although not as cheap as, say, CEL.
Does anyone have any informed comment to contribute?

Andy - Wiltshire is too far away to join in your meetings, but good luck anyway. I think you should be OK in this one, but maybe not very exciting.
Have you looked at CEL or THE? DYOR of course. Both of them have sensible and informative threads. Read esp Robbie12 and pork belly respectively.

Boad.

[njp] 19/9/2002 17:01

matthewa:

Can you clarify your comment about SHP and CCH cost cutting and it's relevance to INT? INT aren't into clinical trials work for biotech, at least not in any major way that I'm aware of, and I used to work with them. They are heavily into generics manufacture and, through recent acquisitions in Europe, do have an involvement in contract manufacture but SHP and CCH's activities will have little impact on them.

As to where the share price is going, the current range seems to be 210-270. Although currently in downtrend I'd be very surprised indeed if it drops below £2. Sure, anything's possible but, given the recent interims indicate they're on track for 21p eps this year and past growth indicates estimates of 24p for 2003 are not unrealistic, profits are stable and it's far more likely that it'll bounce again around 210p as bargain hunters pounce.

[theape] 18/9/2002 23:27

thx mathew.

[matthewa] 18/9/2002 21:07

Second Tier Bio tech Stocks have started to come off recently as the market reliaases the blue chip bios SHP CCH et al are cutting back on all extra expenses in savage cost cutting drives. While there is still the need for patent protection the need for outsourcing is being reduced. Shortered INT a few days ago been coming off ever since.

.

[andyblair] 14/9/2002 16:41

I am a member of an investment club that holds shares in this company. We currently have twelve members and are legally allowed up to twenty. We are based on the Wirral but we have members in Chester and Liverpool as well. We meet once a month in a pub on the Wirral and are looking for additional members to possibly take it up to twenty. If you are interested in joining you can contact me by e-mail in the first instance ([e-mail])and I can give you more details.

Regards
Andy Blair

[boadicea] 08/9/2002 18:05

I thought last week's market reaction to the respectable interims was a little harsh. I am pleased to see the S Telegraph today quotes "analysts' concensus forecast.....£23.7m .... putting the shares on an undemanding PE of 11" and goes on to say "Worth a punt."

After some initial interest in the next day or two I expect all will go very quiet again until the finals approach, so it may well drift back further with the market. Don't go to sleep! One to accumulate on weak days, I think, but as always, dyor.

BOAD.

[jeffian] 05/9/2002 19:19

Looked like a solid set of results today - and yet the share marked down 8p! It's that sort of market, I'm afraid.

Regards, Ian

5 September 2002

The Intercare Group plc

Interim Results Announcement for the Six Months Ended 30 June 2002


The Intercare Group plc, the provider of outsourced supply chain services to the
pharmaceutical industry, announces further substantial increases in sales and
profits ahead of expectations during the six months ended 30 June 2002.
Intercare also announced today the acquisition of LCO Sante for £34.9m, and the
planned opening of new distribution depots in the West Midlands and the South
West.
2002 2001 Increase

Turnover £129.3m £101.3m +28%
Total operating profit* £12.6m £10.7m +17%
Profit before tax* £10.7m £9.1m +18%
Adjusted earnings per share* 9.5p 8.1p +17%
Dividend per share 2.2p 2.1p + 5%


* Before goodwill and licence amortisation.


Highlights

• Further significant growth in turnover, profits and earnings

• Good progress from recently acquired contract manufacturing
companies

• Excellent performance from Distribution Division

• Acquisition today of LCO Sante for £34.9m

• New distribution depots being established in West Midlands and
South West announced today

• Good start to H2

• Excellent prospects for the Group

Commenting on the results, Mr Ken Harvey, Chairman, said:

'Intercare has enjoyed an excellent first half and has started the traditionally
stronger second half well. The Group has positioned itself, through organic
growth and recent acquisitions, as a key beneficiary of the pharmaceutical
outsourcing market.

The opportunities for long-term organic and acquisitive growth for Intercare
remain very attractive and I am confident and optimistic of continuing future
success.'

Enquiries:

The Intercare Group plc Tel: [phone]
John Parker, Chief Executive

[njp] 29/8/2002 18:25

annef - Thanks!

[annef] 29/8/2002 18:10

NJP & Chicken

I emailed INT - interim results due out Thursday 5 September

Regards, Anne

[chicken] 23/8/2002 14:48

ok thanks very much!

[njp] 23/8/2002 13:14

They haven't announced a date yet but they were out on 30th August last year.

[chicken] 23/8/2002 13:07

Guys looking strong again on low volumes! any idea when the interims are?

[whywithpumpkins] 22/8/2002 23:56

this is a quality one, have held for sometime and well in profit, even pays a divi. i to am very cautious over this rally. role on capitulation, we never really got it, and until we've had it we can't go forward confidently.

[njp] 22/8/2002 23:51

Coming very near to interims which I doubt will disappoint. I guess a lot of people who saw this marked down to 210p and below will have thought about baling out today. There may well be more to come but a profit's a profit and the US market can't sustain this bear rally for much longer.

PS I personally have a long term holding and I'm confident we'll see the likes of 290p or thereabouts within the next 6 months.

[chicken] 22/8/2002 20:47

Thanks nice to know im not on my own here. Nice rise today on pretty low volume? any ideas?

[boadicea] 22/8/2002 20:32

This is one of several health/pharmaceutical shares that I consider to be underrated at present - imo of course. So, yes Chicken, I am with you and continue to hold in expectation of steady progress assisted by the opening up of the market as patent restrictions expire. I am not ramping. Quite happy to watch a gradual re-rating. Breaking of good news, large contract etc would be a bonus!

Boad.